Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ryffel

Showing results (31-40 of 194) with videos related to

Pageof 20
Sort By:
Clinical Immunology and Immunopathology|April 1, 1997
Safety considerations of recombinant protein therapy: introductory commentsT J Hayes, B Ryffel
Clinical Nephrology|January 1, 1986
Glomerulonephritis in NZB/W mice: therapeutic effect of cyclosporineH C Gunn, B Ryffel
Parasitology|February 24, 1999
The development of murine cerebral malaria does not require nitric oxide productionN Favre, B Ryffel, W Rudin
Clinical and Experimental Immunology|February 1, 1996
Effect of rapamycin on the expression of the IL-2 receptor (CD25)G Woerly, N Brooks, B Ryffel
Parasitology|February 24, 1999
Parasite killing in murine malaria does not require nitric oxide productionN Favre, B Ryffel, W Rudin
Toxicology|February 13, 2001
Use of transgenic animals to investigate drug hypersensitivityR Moser, V Quesniaux, B Ryffel
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1982
Cyclosporin receptors on human lymphocytesB Ryffel, U Götz, B Heuberger
European Journal of Immunology|October 1, 1988
Comparison of the structure of the murine interleukin 2 (IL 2) receptor on cytotoxic and helper T cell lines by chemical cross-linking of 125I-labeled IL 2B Foxwell, D Taylor, B Ryffel
Transplantation Proceedings|June 1, 1990
Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experimentsA Fahr, P Hiestand, B Ryffel
Transplantation Proceedings|February 1, 1987
Cyclosporine A allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytesB Ryffel, S Müller, B Foxwell
Pageof 20

Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Clinical Immunology and Immunopathology|April 1, 1997
Safety considerations of recombinant protein therapy: introductory commentsT J Hayes, B Ryffel
Clinical Nephrology|January 1, 1986
Glomerulonephritis in NZB/W mice: therapeutic effect of cyclosporineH C Gunn, B Ryffel
Parasitology|February 24, 1999
The development of murine cerebral malaria does not require nitric oxide productionN Favre, B Ryffel, W Rudin
Clinical and Experimental Immunology|February 1, 1996
Effect of rapamycin on the expression of the IL-2 receptor (CD25)G Woerly, N Brooks, B Ryffel
Parasitology|February 24, 1999
Parasite killing in murine malaria does not require nitric oxide productionN Favre, B Ryffel, W Rudin
Toxicology|February 13, 2001
Use of transgenic animals to investigate drug hypersensitivityR Moser, V Quesniaux, B Ryffel
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1982
Cyclosporin receptors on human lymphocytesB Ryffel, U Götz, B Heuberger
European Journal of Immunology|October 1, 1988
Comparison of the structure of the murine interleukin 2 (IL 2) receptor on cytotoxic and helper T cell lines by chemical cross-linking of 125I-labeled IL 2B Foxwell, D Taylor, B Ryffel
Transplantation Proceedings|June 1, 1990
Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experimentsA Fahr, P Hiestand, B Ryffel
Transplantation Proceedings|February 1, 1987
Cyclosporine A allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytesB Ryffel, S Müller, B Foxwell
Pageof 20